ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2392

Impact of the Pattern of Interstitial Lung Disease on Mortality in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis

Namrata Singh1, Jimmy Varghese2, Bryant R. England3, Joshua J. Solomon4, Kaleb Michaud5, Ted R. Mikuls6 and Marin Schweizer7, 1Internal Medicine, University of Iowa Hospitals and Clinics and Iowa City VA, Iowa City, IA, 2Internal Medicine, University of Iowa Hospitals and Clinics, Iowa City, IA, 3Division of Rheumatology & Immunology, Department of Internal Medicine, Nebraska-Western IA VA Health Care System & University of Nebraska Medical Center, Omaha, NE, 4Division of Pulmonary and Critical Care Medicine, National Jewish Health, Denver, CO, 5University of Nebraska Medical Center, Omaha, NE, 6Internal Medicine, Division of Rheumatology, University of Nebraska Medical Center, Omaha, NE, 7Internal Medicine, Iowa City VA, Iowa City, IA

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: interstitial lung disease, meta-analysis, morbidity and mortality and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 7, 2017

Title: Rheumatoid Arthritis – Clinical Aspects Poster III: Comorbidities

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

ABSTRACT

Impact of the Pattern of Interstitial Lung Disease on Mortality in Rheumatoid Arthritis: A systematic review and meta-analysis

Background/Purpose: Interstitial lung disease affects 10-15% of rheumatoid arthritis (RA) patients and carries poor prognosis with a median survival of less than 3 years following diagnosis. ILD can be classified into distinct patterns based on computed tomography or lung histopathology, with the usual interstitial pneumonia (UIP) pattern being the most common. While some studies have shown the UIP pattern to have a higher mortality risk, other studies have not found this association. The purpose of this study was to complete a systematic review and meta-analysis of the association between RA-ILD pattern and mortality risk.

Methods: Pubmed and Embase databases were searched for relevant, published articles from their inception to March 1st, 2017 using the PRISMA guidelines. The MeSH terms used for the search were “rheumatoid arthritis” and “interstitial lung disease”. Inclusion criteria were assessment of ILD pattern (either radiographically or based on histopathology) as a predictor of mortality in RA patients. Studies of connective tissue disease ILD without separate analysis of RA patients were excluded. No exclusions were made based on study design, quality of the study or duration of follow-up. Data was pooled using a random effects model with inverse variance weighting. Cochran’s Q statistic and I2 test were used to test for heterogeneity among the studies. The Newcastle-Ottawa scale (NOS) was used to assess the risk of bias among the included studies.

Results: Five studies fulfilled inclusion and exclusion criteria. Two of the five studies found UIP pattern to be significantly associated with worse survival. In a meta-analytic approach, the UIP pattern was associated with a 2-fold increased risk of mortality (pooled risk ratio=2.03; 95% confidence interval=1.13, 3.66) (Figure 1). The results of the meta-analysis were heterogeneous, I2=67% (p=0.02), with risk ratios for the UIP pattern ranging from 1.09 to 8.62. Three of the five studies were of high quality based on the NOS.

Conclusion: Using a meta-analytic approach, we found UIP pattern to be associated with higher mortality risk. However, there was substantial heterogeneity between studies and a limited number of studies investigating ILD pattern and mortality risk. Further study of mortality risk in RA-ILD is needed with standardized assessment of other RA and patient related factors such as age, gender, smoking history, autoantibody expression, disease activity and pulmonary function tests.

Figure 1. Pooled effect estimate of rheumatoid arthritis interstitial lung disease pattern and mortality risk.


Disclosure: N. Singh, None; J. Varghese, None; B. R. England, None; J. J. Solomon, None; K. Michaud, None; T. R. Mikuls, BMS, 2,Ironwood Pharm, 2,Pfizer Inc, 5,NIH, VA, 2; M. Schweizer, None.

To cite this abstract in AMA style:

Singh N, Varghese J, England BR, Solomon JJ, Michaud K, Mikuls TR, Schweizer M. Impact of the Pattern of Interstitial Lung Disease on Mortality in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/impact-of-the-pattern-of-interstitial-lung-disease-on-mortality-in-rheumatoid-arthritis-a-systematic-review-and-meta-analysis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/impact-of-the-pattern-of-interstitial-lung-disease-on-mortality-in-rheumatoid-arthritis-a-systematic-review-and-meta-analysis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology